Comments
Loading...

Fresh Tracks Therapeutics

FRTXOTCEM
Logo brought to you by Benzinga Data
$0.8959
0.1113.41%
After Hours: 8:56 AM EDT

Fresh Tracks Therapeutics (OTC:FRTX) Stock, Earnings Estimates, EPS, And Revenue

Fresh Tracks Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 15
EPS
$-0.200
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
$8.01M

Analyze the earnings history of Fresh Tracks Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Fresh Tracks Therapeutics (FRTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42023-03-30$-1.50$-1.43-4.90 %
Q32022-11-10$-2.07$-1.89-9.52 %
Q22022-08-11$-0.01$-2.0599.5 %
Q12022-05-12$-3.60$-2.70-33.3 %

Fresh Tracks Therapeutics (FRTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q42023-03-30$2.05M$2.50M-18.0 %
Q32022-11-10$486.00K$430.00K13.0 %
Q22022-08-11$4.32M$3.13M37.9 %
Q12022-05-12$92.00K$140.00K-34.3 %

FAQ

Q

When is Fresh Tracks Therapeutics (OTCEM:FRTX) reporting earnings?

A

Fresh Tracks Therapeutics (FRTX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 15, 2024 for Q4.

Q

What were the latest earnings per share (EPS) for Fresh Tracks Therapeutics (OTCEM:FRTX)?

A

Fresh Tracks Therapeutics (FRTX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 15, 2024 for Q4 and the Actual EPS was $-0.20, which missed the estimate of $0.00.

Q

What were Fresh Tracks Therapeutics’s (OTCEM:FRTX) revenues?

A

Fresh Tracks Therapeutics (FRTX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 15, 2024 for Q4 and the Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.